Administration of LA to mice could simulate the symptoms of COVID-19, including leukopenia, lymphopenia, lymphocyte damage, relative thrombocytopenia, hypercytokinemia, elevated ALT, hypoalbuminemia, hypocalcemia, shock, and renal failure (121). The gene discussed is GPT; the disease is Decreased total leukocyte count.